Peijia Medical Limited (4WO) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.096x

Based on the latest financial reports, Peijia Medical Limited (4WO) has a cash flow conversion efficiency ratio of -0.096x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-235.16 Million ≈ $-274.93 Million USD) by net assets (€2.44 Billion ≈ $2.86 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Peijia Medical Limited worth for the company's overall valuation and market capitalisation.

Peijia Medical Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Peijia Medical Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Peijia Medical Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Peijia Medical Limited ranked by their cash flow conversion efficiency. See Peijia Medical Limited cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Guangdong New Grand Long Packing Co Ltd
SHE:002836
-0.084x
Beijing InHand Networks Technology Co Ltd
SHG:688080
0.071x
Ningbo Tianyi Medical Appliance Co. Ltd.
SHE:301097
N/A
Bank7 Corp
NASDAQ:BSVN
0.064x
Yuanbao Inc. American Depositary Shares
NASDAQ:YB
0.399x
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
0.027x
Nathans Famous Inc
NASDAQ:NATH
-0.133x
CIMB Thai Bank Public Company Limited
BK:CIMBT
-0.088x

Annual Cash Flow Conversion Efficiency for Peijia Medical Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Peijia Medical Limited from 2018 to 2025. View Peijia Medical Limited stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.86 Billion
≈ $2.17 Billion
€-20.89 Million
≈ $-24.42 Million
-0.011x -343.81%
2024-12-31 €2.04 Billion
≈ $2.39 Billion
€-5.18 Million
≈ $-6.06 Million
-0.003x +99.09%
2023-12-31 €2.27 Billion
≈ $2.66 Billion
€-630.91 Million
≈ $-737.60 Million
-0.277x -94.52%
2022-12-31 €2.64 Billion
≈ $3.08 Billion
€-376.20 Million
≈ $-439.81 Million
-0.143x +1.32%
2021-12-31 €3.02 Billion
≈ $3.53 Billion
€-436.37 Million
≈ $-510.16 Million
-0.145x -124.52%
2020-12-31 €2.81 Billion
≈ $3.29 Billion
€-181.10 Million
≈ $-211.72 Million
-0.064x -135.03%
2019-12-31 €-558.21 Million
≈ $-652.60 Million
€-102.59 Million
≈ $-119.94 Million
0.184x -55.23%
2018-12-31 €-94.34 Million
≈ $-110.29 Million
€-38.73 Million
≈ $-45.28 Million
0.411x --

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$403.11 Million
€344.80 Million EUR
Market Cap Rank
#13493 Global
#1396 in Germany
Share Price
€0.52
Change (1 day)
-0.96%
52-Week Range
€0.39 - €0.78
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more